image
Aileron Therapeutics, Inc. ALRN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.87
-13.3 %
$ 62.2 M
Market Cap
-0.93
P/E
BALANCE SHEET
106 M ASSETS
381.70%
Growth Rates
1Year 381.70%
3Years 86.50%
5Years 28.45%
7Years 25.17%
10Years 20.74%
7.71 M LIABILITIES
127.87%
Growth Rates
1Year 127.87%
3Years 22.65%
5Years -6.36%
7Years -33.48%
10Years 6.09%
6.89 M EQUITY
-63.02%
Growth Rates
1Year -63.02%
3Years -17.27%
5Years -18.87%
7Years 10.89%
10Years -5.01%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Aileron Therapeutics, Inc.
image
Current Assets 18.3 M
Cash & Short-Term Investments 17.3 M
Receivables 0
Other Current Assets 953 K
Non-Current Assets 87.7 M
Long-Term Investments 0
PP&E 19 K
Other Non-Current Assets 87.7 M
Current Liabilities 4.38 M
Accounts Payable 1.19 M
Short-Term Debt 96 K
Other Current Liabilities 3.1 M
Non-Current Liabilities 3.33 M
Long-Term Debt 0
Other Non-Current Liabilities 3.33 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 17.3 5.2 3.6 7.0 5.3 10.6 11.9 20.7 3.8 6.2 9.9
Short Term Investments 0 16.0 42.3 6.8 13.0 10.1 38.9 0 0 10.0 4.1
Receivables 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.0 0.6 2.2 2.5 1.3 1.1 1.1 0.4 0.3 0.9 0.3
Total Current Assets 18.3 21.9 48.2 16.3 19.6 21.8 51.8 21.1 4.0 17.1 14.4
PP&E 19 K 0.1 0.3 15 K 6.4 7.3 0.2 0.1 0.4 0.6 1.0
Intangible Assets 79.2 0 0 0 0 0 0 0 0 0 0
Goodwill 6.3 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0.6 0.6 0 63 K 63 K 0 0
Other Long Term Assets 2.2 24 K 24 K 0 0.6 0.7 0.7 0.8 1.5 63 K 0.8
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 106.0 22.0 48.5 16.3 26.5 30.3 52.7 22.0 5.9 17.7 16.1
LIABILITIES
Accounts Payable 1.2 1.7 1.2 1.6 1.5 1.7 1.6 2.0 0.6 1.0 1.8
Short Term Debt 96 K 66 K 0.2 0.2 0.9 0 0 0 0 0 0
Other Current Liabilities 3.1 1.6 3.1 2.2 3.5 3.6 3.3 2.1 1.9 1.2 2.5
Total Current Liabilities 4.4 3.4 4.5 4.0 5.8 5.4 4.9 4.1 2.5 2.1 4.3
Long Term Debt 0 0 69 K 0.2 4.6 5.3 0 0 0 0 0
Deferred Tax Income 3.3 0 0 0 1.6 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 129.8 97.7 0 0
Total Liabilities 7.7 3.4 4.6 4.2 10.4 10.7 4.9 133.8 100.3 2.1 4.3
EQUITY
Common Stock 91 K 91 K 91 K 44 K 28 K 15 K 15 K 4 K 4 K 4 K 4 K
Retained Earnings (288.5) (272.8) (245.5) (219.3) (198.1) (168.5) (136.9) (114.3) (96.2) (83.3) (67.3)
Other Accumulative Comprehensive Income/Loss 63 K 48 K 13 K 2 K 7 K 5 K 33 K (2.1) (1.9) 4 K 3 K
Total Equity 6.9 18.6 43.9 12.2 16.0 19.6 47.8 (111.8) (94.3) 15.6 11.5
Total Liabilities and Equity 106.0 22.0 48.5 16.3 26.5 30.3 52.7 22.0 5.9 17.7 15.8
SHARES OUTSTANDING
Common Shares Outstanding 4.6 4.5 4.4 1.7 1.2 0.7 0.4 0.5 0.5 19 K 19 K